{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack
- RxCUI
- 1301695
- RxNorm name
- {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack
- Display name
- Halobetasol/Lactate (Pack)
- Full name
- {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack
- Term type
- GPCK
- Status
- Active
- Strength
- mixed
- Dose form
- Pack
- Route
- Pack
- Updated
- 2026-07-20 06:55:34
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082012
- Active start
- 082012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| lactic acid | 100 MG / 1 ML | lactate | lactic acid |
| halobetasol propionate | 0.0005 MG / 1 MG | halobetasol | halobetasol propionate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Pack | 746839 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| lactate | 114202 |
| halobetasol | 41208 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack | NAMES |
| RxNorm Name | {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack | NAMES |
| TTY | GPCK | ATTRIBUTES |
| RxCUI | 1301695 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | halobetasol | |
| ATC | G01AD | Organic acids | ATC1-4 | lactic acid | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | halobetasol |
| FDASPL | N0000175833 | Acidifying Activity | MOA | has_moa | lactic acid |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | halobetasol |
| MEDRT | D002990 | Clobetasol | CHEM | has_ingredient | halobetasol propionate |
| MEDRT | D002990 | Clobetasol | CHEM | has_ingredient | halobetasol |
| MEDRT | D019344 | Lactic Acid | CHEM | has_ingredient | lactic acid |
| MEDRT | D019344 | Lactic Acid | CHEM | has_ingredient | lactate |
| MEDRT | D003872 | Dermatitis | DISEASE | may_prevent | lactic acid |
| MEDRT | D003872 | Dermatitis | DISEASE | may_treat | lactic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lactic acid |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | lactic acid |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | halobetasol |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | halobetasol |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | halobetasol |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | halobetasol |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | halobetasol propionate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | halobetasol |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | halobetasol |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | halobetasol propionate |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | halobetasol |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | halobetasol |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | halobetasol propionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | halobetasol propionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | halobetasol |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | halobetasol |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | halobetasol propionate |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | lactic acid |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | halobetasol |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | halobetasol propionate |
| MEDRT | N0000008663 | Decreased Immunologically Active Molecule Activity | PE | has_pe | halobetasol |
| MEDRT | N0000008663 | Decreased Immunologically Active Molecule Activity | PE | has_pe | halobetasol propionate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | halobetasol |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | halobetasol propionate |
| MEDRT | N0000009735 | Decreased Skin Keratinization | PE | has_pe | lactic acid |
| MEDRT | N0000009035 | Emollient Activity | PE | has_pe | lactic acid |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | halobetasol |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | halobetasol propionate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | TTY | GPCK |
| CODES | RxCUI | 1301695 |
| NAMES | Prescribable Synonym | halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack) |
| NAMES | RXNAV_STR | {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack |
| NAMES | RxNorm Name | {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack |